There is: No evidence that Epitalon can shrink existing tumors in humans No human clinical trials testing its use in oncology No mechanistic studies confirming how Epitalon affects tumor microenvironments or immune evasion in vivo What we do have is a compelling preventive profile in animal models, especially where aging and genetic susceptibility intersect
In addition, fatigue symptoms ranked as the second most common complaint in these online posts despite rarely being reported in clinical trials
Implications for ageing
This means its essential to work with a licensed healthcare provider who can monitor your progress and adjust your treatment approach accordingly
Tc dng h tr: Cung cp m, lm mm da, gip y li, lm chm qu trnh lo ha, lm gim np nhn quanh mt
Peer review Peer review information Nature Communications thanks Luca Chiovato and the other, anonymous, reviewer(s) for their contribution to the peer review of this work